PROCEPT BioRobotics Corporation APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition
PROCEPT BioRobotics Corporation (PRCT) reported APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition of $14.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition · last filed 2026-08-05
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2026-06-30 was $14.73M, a 20.65% increase year-over-year.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2026-03-31 was $13.27M, a 29.24% increase year-over-year.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2025-09-30 was $14.63M, a 67.84% increase year-over-year.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2025-06-30 was $12.21M, a 49.30% increase year-over-year.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2025 was $48.11M, a 47.00% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2024 was $32.73M, a 50.87% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2023 was $21.69M, a 103.30% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation apic, share-based payment arrangement, other, increase for cost recognition for fiscal 2022 was $10.67M, a 181.09% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.73M 10-Q · filed 2026-08-05 | $28.00M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $13.27M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $48.11M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $14.63M 10-Q · filed 2025-11-05 | $26.83M derived: sum of 2 quarters · filed 2026-08-05 | $37.10M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $12.21M 10-Q · filed 2026-08-05 | $22.47M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $10.27M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $32.73M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $8.71M 10-Q · filed 2025-11-05 | $16.89M derived: sum of 2 quarters · filed 2025-11-05 | $23.53M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $8.18M 10-Q · filed 2025-11-05 | $14.81M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $6.64M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $21.69M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $5.96M 10-Q · filed 2024-10-28 | $11.61M derived: sum of 2 quarters · filed 2024-10-28 | $15.75M derived: sum of 3 quarters · filed 2024-10-28 | |
| 2023-06-30 | $5.65M 10-Q · filed 2024-10-28 | $9.79M derived: sum of 2 quarters · filed 2024-10-28 | ||
| 2023-03-31 | $4.14M 10-Q · filed 2024-10-28 | |||
| 2022-12-31 | $10.67M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $3.23M 10-Q · filed 2023-11-02 | $5.90M derived: sum of 2 quarters · filed 2023-11-02 | $7.45M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $2.68M 10-Q · filed 2023-11-02 | $4.23M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $1.55M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $3.80M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $925.00K 10-Q · filed 2022-11-04 | $1.65M derived: sum of 2 quarters · filed 2022-11-04 | $2.30M derived: sum of 3 quarters · filed 2022-11-04 | |
| 2021-06-30 | $725.00K 10-Q · filed 2022-11-04 | $1.38M derived: sum of 2 quarters · filed 2022-11-04 | ||
| 2021-03-31 | $650.00K 10-Q · filed 2022-11-04 | |||
| 2020-12-31 | $2.17M 10-K · filed 2022-03-22 | |||
| 2020-09-30 | $563.00K 10-Q · filed 2021-11-05 | $1.01M derived: sum of 2 quarters · filed 2021-11-05 | $1.57M derived: sum of 3 quarters · filed 2021-11-05 | |
| 2020-06-30 | $445.00K 10-Q · filed 2021-11-05 | $1.01M derived: sum of 2 quarters · filed 2021-11-05 | ||
| 2020-03-31 | $561.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |